| Trial ID: | L0205 |
| Source ID: | NCT04080947
|
| Associated Drug: |
Montelukast
|
| Title: |
The Leukotriene Receptor Antagonist Montelukast in the Treatment of Non-alcoholic Steatohepatitis
|
| Acronym: |
--
|
| Status: |
Completed
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Steatohepatitis, Nonalcoholic
|
| Interventions: |
Drug: Control group|Drug: Montelukast group
|
| Outcome Measures: |
Fibro-scan score|Liver Panel|HOMA-IR|8-OHdG|TNF-Alpha|hyaluronic acid|TGF-??1|Assessment of drugs tolerability: Side effects
|
| Sponsor/Collaborators: |
Sadat City University
|
| Gender: |
All
|
| Age: |
18 Years to 60 Years ?? (Adult)
|
| Phases: |
Phase 1/Phase 2
|
| Enrollment: |
56
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: Double (Participant, Investigator)|Primary Purpose: Treatment
|
| Start Date: |
August 1, 2019
|
| Completion Date: |
March 15, 2022
|
| Results First Posted: |
--
|
| Last Update Posted: |
March 16, 2022
|
| Locations: |
Faculty of Medicine, Shib??n Al Kawm, Menoufia, Egypt
|
| URL: |
https://ClinicalTrials.gov/show/NCT04080947
|
